Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

NCT00206492 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped halted by the PI only 3 of 45 subjects were accrued.

Conditions

Breast Cancer

Interventions

DRUG: Iressa
DRUG: Tamoxifen

Sponsor

Baylor Breast Care Center

Collaborators

[object Object]